缩小理论与实践之间的差距:为临床改进项目量化奥维德合成的影响
Journal for nurses in professional development
|October 31, 2024
概括
这项研究评估了Ovid Synthesis,这是一种支持基于证据的实践 (EBP) 实施的工具. 研究结果显示,EBP的成功取决于标准化,协作和患者的结果,而Ovid Synthesis有助于这些优先事项.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 信息科学 信息科学 信息科学
背景情况:
- 实施基于证据的实践 (EBP) 对医疗保健质量至关重要.
- 卫生系统需要有效的工具来支持EBP倡议.
研究的目的:
- 评估卫生系统领导者对奥维德合成的使用情况.
- 确定EBP成功实施的关键因素.
- 评估Ovid综合如何支持EBP优先事项.
主要方法:
- 计划评估研究.
- 参与了18名使用Ovid合成的卫生系统领导人.
- 工具利用和感知影响的定性评估.
主要成果:
- 标准化,协作,传播和患者的结果对于EBP的成功至关重要.
- 奥维德综合有效地支持这些重点优先事项.
- 卫生领导人强调衡量EBP的投资回报率.
结论:
- 奥维德综合是支持EBP在卫生系统中的实施的宝贵工具.
- 通过ROI证明EBP的价值对于持续投资至关重要.
- 成功的EBP需要关注标准化,协作和以患者为中心的护理.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Methods of Documentation II: POMR
917
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
917
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Agonism and Antagonism: Quantification
330
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
330
Drug Administration and Therapy Phases: Overview
411
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
411


